Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TG THERAPEUTICS, INC. | 9,778,086 | reported | 08 Jan 2026 | tx 49+29,372,859−11,482,956 |
| XTL BIOPHARMACEUTICALS LTD | 3,500,000 | reported | 10 Oct 2008 | tx 2+3,500,000−3,083,333 |
| Fortress Biotech, Inc. | 2,276,562 | reported | 18 Mar 2026 | tx 19+16,222,192 |
| KERYX BIOPHARMACEUTICALS INC | 1,320,418 | reported | 10 May 2010 | tx 222+4,893,656−2,229,863 |
| GENTA INC DE/ | 565,088 | reported | 28 Jun 2004 | tx 9+35,000−42,850 |
| MUSTANG BIO, INC. | 49,637 | reported | 05 Jul 2023 | tx 6+133,107 |
| AVENUE THERAPEUTICS, INC. | 24,663 | reported | 07 Aug 2018 | tx 1+14,663 |
| Checkpoint Therapeutics, Inc. | 0 | reported | 30 May 2025 | tx 13+300,768−187,007 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Mar 2026 | GRANT_AWARD | Fortress Biotech, Inc. | 475,424 | 0.00 USD | |
| 08 Jan 2026 | GRANT_AWARD | TG THERAPEUTICS, INC. | 622,000 | 0.00 USD | |
| 05 Nov 2025 | GIFT | TG THERAPEUTICS, INC. | 3,865,126 | 0.00 USD | |
| 05 Nov 2025 | GIFT | TG THERAPEUTICS, INC. | 803,717 | 0.00 USD | |
| 30 May 2025 | TENDER | Checkpoint Therapeutics, Inc. | 187,007 | — | |
| 29 May 2025 | GRANT_AWARD | Checkpoint Therapeutics, Inc. | 50,000 | 1.29 USD | |
| 28 May 2025 | GRANT_AWARD | Checkpoint Therapeutics, Inc. | 12,195 | 0.00 USD | |
| 29 Jan 2025 | GRANT_AWARD | TG THERAPEUTICS, INC. | 750,000 | 0.00 USD | |
| 01 Jan 2025 | GRANT_AWARD | Fortress Biotech, Inc. | 454,153 | 0.00 USD | |
| 13 Dec 2024 | GRANT_AWARD | Checkpoint Therapeutics, Inc. | 12,638 | 0.00 USD | |
| 14 May 2024 | GRANT_AWARD | Checkpoint Therapeutics, Inc. | 32,051 | 0.00 USD | |
| 14 May 2024 | GRANT_AWARD | Checkpoint Therapeutics, Inc. | 50,000 | 0.00 USD | |
| 06 Jan 2024 | GRANT_AWARD | TG THERAPEUTICS, INC. | 1,001,908 | 0.00 USD | |
| 01 Jan 2024 | GRANT_AWARD | Fortress Biotech, Inc. | 216,465 | 0.00 USD | |
| 14 Nov 2023 | PURCHASE | Fortress Biotech, Inc. | 147,058 | 1.70 USD | |
| 14 Nov 2023 | PURCHASE | Fortress Biotech, Inc. | 147,058 | 0.00 USD | deriv |
| 11 Aug 2023 | PURCHASE | TG THERAPEUTICS, INC. | 100,000 | 10.13 USD | |
| 05 Jul 2023 | GRANT_AWARD | MUSTANG BIO, INC. | 7,246 | 0.00 USD | |
| 13 Jun 2023 | GRANT_AWARD | Checkpoint Therapeutics, Inc. | 17,483 | 0.00 USD | |
| 29 Jul 2022 | GRANT_AWARD | MUSTANG BIO, INC. | 71,664 | 0.00 USD | |
| 12 Mar 2023 | GRANT_AWARD | TG THERAPEUTICS, INC. | 985,000 | 0.00 USD | |
| 10 Feb 2023 | PURCHASE | Fortress Biotech, Inc. | 1,197,604 | 0.84 USD | first after silence |
| 01 Jan 2023 | GRANT_AWARD | Fortress Biotech, Inc. | 1,219,294 | 0.00 USD | |
| 20 Jul 2022 | GRANT_AWARD | TG THERAPEUTICS, INC. | 1,900,000 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | Checkpoint Therapeutics, Inc. | 47,619 | 0.00 USD |
5 purchases reported after at least 12 months of silence — most recent on 10 Feb 2023.